Clinical Trials Browser

Phase 4 × INDUSTRY × aldesleukin × Clear all

NCT01856023 2023-12-05

PROCLIVITY02

Phase 4 Terminated

29 enrolled 9 charts

Melanoma, Neoplasm Metastasis, Skin Neoplasms

NCT00414765 2021-06-08

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Phase 4 Completed

26 enrolled 7 charts

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT01683188 2021-02-01

PROCLIVITY01

Phase 4 Terminated

Melanoma, Skin Neoplasms